Portfolio company
Aizen Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
Graph Therapeutics
This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.
Animate Biosciences
This company develops AI-designed peptide therapeutics for patients with inflammatory and fibrotic diseases using multi-omic data from regenerative species.
Ternary Therapeutics
This company develops an artificial intelligence platform to design molecular glue therapeutics for healthcare providers and pharmaceutical partners to treat complex diseases.
Deepcure
This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.
Meddenovo
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
Evozyne
The company creates synthetic therapeutic proteins using generative artificial intelligence for pharmaceutical and biotechnology organisations to treat immune-mediated diseases and genetic disorders.
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
